Trial
NCT05346653
The Hemodynamic Effects of SGLT2i in Acute Decompensated Heart Failure
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Chicago
Collaborators
—
Condition
Acute Decompensated Heart Failure
Intervention
SGLT2i
Why stopped
Enrollment goals were not met.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-04